Last reviewed · How we verify
NCT06310135
Filtered Eyewear to Prevent Light-induced Melatonin Suppression - Aim 1
NA trial testing Filtered Eyewear in Sleep Quality in 29 participants. Completed in 31 October 2024.
31 October 2024
Quick facts
| Lead sponsor | Icahn School of Medicine at Mount Sinai |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 29 |
| Start date | 1 May 2024 |
| Primary completion | 31 October 2024 |
| Estimated completion | 31 October 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Filtered Eyewear
- Unfiltered Eyewear
- No Filters
Conditions studied
- Sleep Quality — all drugs for Sleep Quality →
Sponsor
Icahn School of Medicine at Mount Sinai
Who can join
18 and older, any sex, with Sleep Quality. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to determine the relative effectiveness of monocular and binocular light exposures, with and without selective blue-blocking filtering, on nocturnal melatonin suppression, subjective sleepiness, and visual performance of night shift workers.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Impact of a Blue-Blocking Filter Over One Eye on Health and Performance Outcomes and Its Implications for Night Workers.
Figueiro MG, Bullough JD, Rizvydeen M, Plitnick B, et al · · 2026 · PMID 41353624 · DOI 10.1177/10998004251406550
Verify or expand the search:
- PubMed search for NCT06310135
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sleep Quality
Currently open trials in the same condition.
- NCT07421960 — Investigation of the Relationship Between Periodontitis and Sleep Quality · recruiting
- NCT07071324 — CF Wellness Program · NA · recruiting
- NCT07345260 — The Effects of a Nutritional Supplement on Sleep Quality · NA · recruiting
- NCT07319117 — Evaluation of the Impact of a Nutritional Formulation on Cognitive Performance Following Stress Exposure. · NA · recruiting
- NCT07274553 — Mindfulness-Based Stress Reduction for Adolescents: Effects on Game Addiction, Stress, and Sleep · NA · active not recruiting
Other Icahn School of Medicine at Mount Sinai trials
Trials by the same sponsor.
- NCT07094308 — The LIFT-ECHO Last Mile Project · NA · not yet recruiting
- NCT07291427 — Chronic Subdural Hematoma Embolization With Detachable Coils · not yet recruiting
- NCT07194187 — High Intensity Focused Ultrasound (HIFU) Ablation for Treatment of Prostate Tissue in Bladder Outlet Obstruction · NA · not yet recruiting
- NCT07260916 — Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation · NA · not yet recruiting
- NCT07487948 — Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06310135 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Icahn School of Medicine at Mount Sinai
- Last refreshed: 5 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06310135.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing